Irineos Papakyriacou
Assistant with doctoral duties at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Yumeng Mao
- E-mail:
- irineos.papakyriacou@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
Publications
Recent publications
-
Part of Cancer Immunology Research, p. 1467-1483, 2026
- DOI for Cancer intrinsic protein neddylation modulates the intra-tumoral immune landscape to constrain immune checkpoint blockade therapy
- Download full text (pdf) of Cancer intrinsic protein neddylation modulates the intra-tumoral immune landscape to constrain immune checkpoint blockade therapy
-
2026
-
Part of Nature Communications, 2024
- DOI for Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
- Download full text (pdf) of Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
-
Part of Journal of Clinical Investigation, 2023
- DOI for IL-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
- Download full text (pdf) of IL-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
All publications
Articles in journal
-
Part of Cancer Immunology Research, p. 1467-1483, 2026
- DOI for Cancer intrinsic protein neddylation modulates the intra-tumoral immune landscape to constrain immune checkpoint blockade therapy
- Download full text (pdf) of Cancer intrinsic protein neddylation modulates the intra-tumoral immune landscape to constrain immune checkpoint blockade therapy
-
Part of Nature Communications, 2024
- DOI for Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
- Download full text (pdf) of Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
-
Part of Journal of Clinical Investigation, 2023
- DOI for IL-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
- Download full text (pdf) of IL-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy